Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03915002 · ClinicalTrials.gov registry record
Integrated Approaches for Identifying Molecular Targets in Liver Disease
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 155
- Enrollment target
NCT03915002 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 155 participants.
The verdict
NCT03915002 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
To provide a framework for successful clinical trials testing novel targets for therapy in liver disease. To identify molecular and cellular drivers of liver disease to provide a molecular classification and study the determinants or key drivers of disease progression. Consecutive patients admitted with steatohepatitis (alcoholic or non-alcoholic) will be enrolled in this study where liver tissue, blood and stool will be collected to discover and validate factors associated with diagnosis, severity, histological characteristics, development of decompensations, progression of disease and survival.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2019-06-13 |
| Est. Completion | 2023-04-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03915002
The ClinicalTrials.gov registry entry for NCT03915002 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03915002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03915002 about?
NCT03915002 is a clinical study titled "Integrated Approaches for Identifying Molecular Targets in Liver Disease". To provide a framework for successful clinical trials testing novel targets for therapy in liver disease. To identify molecular and cellular drivers of liver disease to provide a molecular classification and study the determinants or key drivers of disease progression. Consecutive patients admitte...
What is the current status of trial NCT03915002?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2019-06-13. Estimated completion is 2023-04-12.
Who is sponsoring clinical trial NCT03915002?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.